The Limners and Bards Limited (JMSE:LAB)
Jamaica · Delayed Price · Currency is JMD 1.050
0.00 (0.00%)
At close: Sep 25, 2026
The Limners and Bards Income Statement
Financials in millions JMD. Fiscal year is November - October.
Millions JMD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| 811.31 | 920.18 | 958.13 | 1,125 | 1,345 | 1,227 | |
Revenue Growth | -13.01% | -3.96% | -14.81% | -16.36% | 9.58% | 34.60% |
Cost of Revenue | 533.51 | 570.54 | 602.83 | 735.83 | 870.48 | 851.4 |
Gross Profit | 277.8 | 349.64 | 355.3 | 388.92 | 474.31 | 375.81 |
Selling, General & Admin | 303.17 | 308.18 | 284.01 | 341.53 | 316.98 | 237.26 |
Operating Expenses | 301.77 | 306.78 | 281.37 | 341.61 | 321.58 | 239.88 |
Operating Income | -23.97 | 42.85 | 73.93 | 47.31 | 152.73 | 135.93 |
Interest Expense | -11.74 | -8.71 | -9.13 | -8.83 | -9.11 | -6.97 |
Interest & Investment Income | 13.63 | 16.04 | 19.79 | 10.58 | 7.04 | 8.38 |
Currency Exchange Gain (Loss) | -2.67 | -2.67 | 5.76 | 2.99 | -7.09 | 17.43 |
Other Non Operating Income (Expenses) | 1.46 | -1.82 | -1.19 | -2.29 | -1.38 | -1.34 |
EBT Excluding Unusual Items | -23.28 | 45.7 | 89.15 | 49.75 | 142.2 | 153.43 |
Gain (Loss) on Sale of Investments | 0.12 | -0.01 | 0.06 | -0.06 | -0.07 | 0.07 |
Gain (Loss) on Sale of Assets | 0.19 | 0.17 | - | 6.87 | 0.93 | - |
Pretax Income | -22.97 | 45.86 | 89.21 | 56.55 | 143.06 | 153.5 |
Income Tax Expense | -2.74 | 5.67 | 6.27 | -0.76 | -0.98 | -2.05 |
Net Income | -20.24 | 40.19 | 82.95 | 57.32 | 144.04 | 155.55 |
Net Income to Common | -20.24 | 40.19 | 82.95 | 57.32 | 144.04 | 155.55 |
Net Income Growth | - | -51.55% | 44.72% | -60.21% | -7.40% | 22.40% |
Shares Outstanding (Basic) | 946 | 946 | 946 | 946 | 946 | 946 |
Shares Outstanding (Diluted) | 946 | 946 | 946 | 946 | 946 | 946 |
Shares Change | -9.20% | - | - | - | - | - |
EPS (Basic) | -0.02 | 0.04 | 0.09 | 0.06 | 0.15 | 0.16 |
EPS (Diluted) | -0.02 | 0.04 | 0.09 | 0.06 | 0.15 | 0.16 |
EPS Growth | - | -51.55% | 44.72% | -60.21% | -7.40% | 22.40% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
Free Cash Flow | -28.82 | -75.93 | 66.79 | 9.16 | 19.55 | 133.19 |
Free Cash Flow Per Share | -0.03 | -0.08 | 0.07 | 0.01 | 0.02 | 0.14 |
Dividend Per Share | - | - | 0.026 | - | - | 0.049 |
Dividend Growth | - | - | - | - | - | 45.00% |
Gross Margin | 34.24% | 38.00% | 37.08% | 34.58% | 35.27% | 30.62% |
Operating Margin | -2.96% | 4.66% | 7.72% | 4.21% | 11.36% | 11.08% |
Profit Margin | -2.49% | 4.37% | 8.66% | 5.10% | 10.71% | 12.68% |
Free Cash Flow Margin | -3.55% | -8.25% | 6.97% | 0.81% | 1.45% | 10.85% |
EBITDA | -4.17 | 63.72 | 93.94 | 64.32 | 167.15 | 147.61 |
EBITDA Margin | -0.51% | 6.93% | 9.80% | 5.72% | 12.43% | 12.03% |
D&A For EBITDA | 19.8 | 20.87 | 20.02 | 17.01 | 14.42 | 11.67 |
EBIT | -23.97 | 42.85 | 73.93 | 47.31 | 152.73 | 135.93 |
EBIT Margin | -2.96% | 4.66% | 7.72% | 4.21% | 11.36% | 11.08% |
Effective Tax Rate | - | 12.37% | 7.02% | - | - | - |